Market Overview - U.S. stocks experienced a decline, with the Dow Jones index falling over 100 points, down 0.28% to 48,229.87, NASDAQ slipping 0.26% to 23,359.33, and S&P 500 dropping 0.26% to 6,878.07 [1] - European shares also fell, with the eurozone's STOXX 600 down 0.14%, Spain's IBEX 35 Index down 0.27%, London's FTSE 100 down 0.09%, and France's CAC 40 down 0.23% [6] - Asian markets closed mixed, with Hong Kong's Hang Seng Index down 0.87%, China's Shanghai Composite up 0.09%, and India's BSE Sensex up 0.64% [7] Commodities - In commodity trading, oil increased by 0.1% to $58.02, while gold decreased by 0.8% to $4,351.00. Silver fell 7.3% to $72.255, and copper dropped 1.9% to $5.6710 [5] Company News - Anghami Inc. shares surged 50% to $3.7306 following a year-over-year increase in H1 results [9] - Vanda Pharmaceuticals Inc. saw a 32% increase in shares to $9.28 after receiving FDA approval for NEREUS [9] - Intelligent Bio Solutions Inc. shares rose 102% to $8.27 due to a strategic manufacturing partnership with Syrma Johari MedTech [9] - Corcept Therapeutics Incorporated shares plummeted 52% to $34.04 after receiving a Complete Response Letter from the FDA [9] - FuelCell Energy, Inc. shares fell 10% to $7.18 after filing for an amended common stock offering [9] - SMX Public Limited Company shares dropped 37% to $32.30 [9] Economic Indicators - U.S. initial jobless claims decreased by 16,000 to 199,000, better than market estimates of 220,000 [10] - U.S. crude oil inventories, excluding the Strategic Petroleum Reserve, fell by 1.934 million barrels, marking the largest weekly decline since mid-November, compared to market estimates of a 0.9 million-barrel decrease [10][2]

Summary of Key Points Core Viewpoint - FuelCell Energy, Inc. (NASDAQ:FCEL) experienced a significant decline in share price following the announcement of an amended common stock offering, which allows the company to sell up to $200 million in shares [1]. Company Specifics - FuelCell Energy shares dropped by 8.9%, closing at $7.23 after the announcement of the amended sales agreement [1]. - Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a remarkable increase of 107% in share price, reaching $8.51, due to a strategic manufacturing partnership with Syrma Johari MedTech [4]. - ESH Acquisition Corp. (NASDAQ:ESHA) gained 59% to $22.86, while Northann Corp. (NYSE:NCL) rose by 58.2% to $0.3071 [4]. - Aimei Health Technology Co., Ltd (NASDAQ:AFJK) shares surged by 50.3% to $127.00 [4]. - Anghami Inc. (NASDAQ:ANGH) reported a year-over-year increase in H1 results, leading to a 44.6% rise in share price to $3.6000 [4]. - Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares increased by 33.1% to $9.36 after receiving FDA approval for NEREUS [4]. - Datavault AI Inc. (NASDAQ:DVLT) gained 32% to $0.6802, while Oriental Rise Holdings Limited (NASDAQ:ORIS) jumped 31% to $1.6001 following a non-binding letter of intent to acquire Hubei Daguan Tea Industry Group [4]. - Urgent.ly Inc. (NASDAQ:ULY) rose 31% to $3.6000 after adjourning its annual stockholder meeting due to insufficient votes [4]. - Momentus Inc. (NASDAQ:MNTS) gained 26.4% to $6.53, and Axsome Therapeutics, Inc. (NASDAQ:AXSM) rose 16.1% to $172.90 after announcing plans to file a new drug application [4]. Market Movements - Corcept Therapeutics Incorporated (NASDAQ:CORT) saw a significant decline of 50.8% to $34.51 after receiving a Complete Response Letter from the FDA [4]. - SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 39.2% to $31.30, while Delixy Holdings Limited (NASDAQ:DLXY) dipped 37.2% to $0.8853 [4]. - MultiSensor AI Holdings, Inc. (NASDAQ:MSAI) declined by 30.7% to $0.2831, and Profusa, Inc. (NASDAQ:PFSA) fell 21.3% to $0.0958 after announcing a new distributor partnership in France [4]. - NIO Inc. (NYSE:NIO) experienced a drop of 9.2% to $4.9950, and Wheels Up Experience Inc. (NYSE:UP) fell 6.3% to $0.5844 [4].

U.S. stocks traded mostly lower this morning, with the Dow Jones index falling more than 50 points on Wednesday.Following the market opening Wednesday, the Dow traded down 0.09% to 48,322.35 while the NASDAQ slipped 0.01% to 23,417.48. The S&P 500 also fell, dropping, 0.04% to 6,893.58.Check This Out: How To Earn $500 A Month From UniFirst Stock Ahead Of Q1 EarningsLeading and Lagging SectorsInformation technology shares rose by 0.2% on Wednesday.In trading on Wednesday, real estate stocks fell by 0.3%.Top ...

Market Overview - U.S. stocks traded mostly lower, with the Dow Jones index falling more than 50 points, down 0.09% to 48,322.35, NASDAQ slipping 0.01% to 23,417.48, and S&P 500 dropping 0.04% to 6,893.58 [1] - Information technology shares rose by 0.2%, while real estate stocks fell by 0.3% [1] Economic Indicators - U.S. initial jobless claims declined by 16,000 to 199,000 in the week ending Dec. 27, compared to market estimates of 220,000 [2][7] Commodity Market - Oil traded up 0.5% to $58.24, while gold traded down 0.7% at $4,355.20 [4] - Silver fell 7.5% to $72.045, and copper decreased by 1.8% to $5.6805 [4] European Market - European shares were lower, with the eurozone's STOXX 600 slipping 0.1%, Spain's IBEX 35 Index falling 0.3%, London's FTSE 100 down 0.1%, and France's CAC 40 down 0.2% [5] Asian Market - Asian markets closed mixed, with Hong Kong's Hang Seng Index falling 0.87%, China's Shanghai Composite gaining 0.09%, and India's BSE Sensex gaining 0.64% [6] Company Performance - Anghami Inc. shares surged 54% to $3.84 after reporting a year-over-year increase in H1 results [9] - Northann Corp. shares increased by 72% to $0.3332 [9] - Intelligent Bio Solutions Inc. shares rose 56% to $6.38 following a strategic manufacturing partnership announcement [9] - Corcept Therapeutics shares dropped 47% to $37.40 after receiving a Complete Response Letter from the FDA [9] - Delixy Holdings Limited shares fell 29% to $1.0001 [9] - SMX Public Limited Company shares decreased by 22% to $40.00 [9]

Core Insights - Intelligent Bio Solutions Inc. will participate in the 21st Annual Emerging Growth Equity Conference hosted by Noble Capital Markets on December 2-3, 2025 [1] Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [4] - The company’s Intelligent Fingerprinting Drug Screening System utilizes fingerprint sweat analysis, aiming to revolutionize portable testing with potential applications in various fields [4] - The system is designed to be hygienic and cost-effective, screening for recent drug use, including opiates, cocaine, methamphetamine, and cannabis, with results available in under ten minutes [4] - Current customer segments outside the U.S. include construction, manufacturing, engineering, transport and logistics, mining, drug treatment organizations, and coroners [4] Conference Details - The conference will take place at Florida Atlantic University, Boca Raton, FL, with Intelligent Bio Solutions scheduled to present on December 3, 2025, at 11:00 a.m. Eastern Time [2] - A webcast recording of the presentation will be available on the company's investor relations website and Noble's website for 90 days post-event [2]

Core Viewpoint - Intelligent Bio Solutions Inc. has integrated Arabic as the second international language into its Intelligent Fingerprinting Drug Screening System, enhancing accessibility for Arabic-speaking organizations and reinforcing its presence in the Middle East [1][2][4]. Company Developments - The integration of Arabic follows the company's expansion plans in the Middle East through a partnership with Ivy Diagnostics, targeting a market where Arabic is spoken by approximately 450 million people [2][4]. - The addition of Arabic is expected to improve usability for organizations in safety-critical industries, law enforcement, and drug rehabilitation, aligning with the growing global demand for innovative drug testing solutions [2][3]. Market Potential - The workplace drug testing market in Saudi Arabia is projected to reach $64.5 million by 2030, indicating significant growth opportunities for the company in the region [3]. - The integration of Arabic will facilitate the incorporation of the company's technology into existing safety protocols, enhancing workplace safety standards [3]. Strategic Growth - The integration of Arabic is a key milestone in the company's broader international growth strategy, which includes scaling operations across North and South America, Europe, Asia Pacific, and the Middle East [4]. - The company aims to expand its presence in 19 countries and has made strategic milestones, including a recent FDA 510(k) submission and plans to enter the multi-billion dollar U.S. market in 2025 [4].

Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [6] - The company aims to revolutionize portable testing via fingerprint sweat analysis, which is designed to be hygienic and cost-effective, screening for recent drug use in workplace settings [6] Market Opportunity - The Spanish drug testing market is projected to reach $448 million by 2030, driven by increasing drug abuse prevention efforts, growing acceptance of drug screening for safety, and rising illicit drug use [4] - Major Spanish accounts currently require 1,000 drug testing cartridges per month, indicating a strong demand for INBS' technology [3] Strategic Partnerships - INBS has expanded its access to fingerprint drug testing in Spain and Andorra through a collaboration with Detecto, a division of MTB Distribuciones Tecnologicas SL, which is a leading provider of drug testing solutions in the region [1][2] - Detecto has successfully integrated INBS' solution into existing security protocols for major clients, including Metro Barcelona and a large mine operated by Rio Tinto, enhancing workplace safety [3] Product Acceptance - The fingerprint drug testing system has been well received due to its non-invasive nature, ease of collection, and increased acceptance among workers, along with reduced maintenance costs due to yearly calibration [3] - Detecto is broadening its focus to include law enforcement and rehabilitation sectors, as well as engaging with the maritime industry, indicating strong growth potential in various sectors [4] Industry Focus - Detecto provides consulting services regarding substance abuse in the workplace, emphasizing worker safety and well-being, particularly in high-risk sectors [5] - The company offers training and information on new drugs and technologies, positioning itself as a key player in the prevention and treatment of addictive behaviors in Spain [5]

As filed with the Securities and Exchange Commission on September 11, 2023 Registration No. 333-273219 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELLIGENT BIO SOLUTIONS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) Delaware 3829 82-1512711 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT ...